Interventions to improve antipsychotic medication adherence: Review of recent literature

Journal of Clinical Psychopharmacology

Volumn 23, Issue 4, 2003, Pages 389-399

  Dolder, Christian R ^a,b   Lacro, Jonathan P ^a,b   Leckband, Susan ^b   Jeste, Dilip V ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

AFFECT; BEHAVIOR; CLINICAL TRIAL; DATA BASE; HOSPITALIZATION; HUMAN; PATIENT COMPLIANCE; PATIENT EDUCATION; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; PUBLICATION; REVIEW; SCHIZOPHRENIA; SOCIAL STATUS;

ADULT; ANTIPSYCHOTIC AGENTS; FEMALE; HUMANS; MALE; PATIENT COMPLIANCE; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 0041632398     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000085413.08426.41     Document Type: Review

References (34)

1. Wyatt RJ, Henter I, Leary MC, et al. An economic evaluation of schizophrenia - 1991. Soc Psychiatry Psychiatr Epidemiol. 1995;30:196-205.
2. Rice DP. The economic impact of schizophrenia. J Clin Psychiatry. 1999;60:4-6.
3. Terkelsen KG, Menikoff A. Measuring the costs of schizophrenia. Implications for the post-institutional era in the US. Pharmacoeconomics. 1995;8:199-222.
4. Weiden PJ, Olfson M. Cost of relapse in schizophrenia. Schizophr Bull. 1995;21:419-429.
5. Fenton WS, Blyler CR, Heinssen RK. Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophr Bull. 1997;23:637-651.
6. Lacro JP, Dunn LB, Dolder CR, et al. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatr. 2002;63:892-909.
7. Dolder CR, Lacro JP, Dunn LB, et al. Medication adherence: is there a difference between typical and atypical agents? Am J Psychiatry. 2002;159:103-108.
8. Meichenbaum D, Turk DC. Facilitating Treatment Adherence: A Practitioner's Guidebook. New York: Plenum; 1987:36-37.
9. Kampman O, Lehtinen K. Compliance in psychoses. Acta Psychiatr Scand. 1999;100:167-175.
10. Roter DL, Hall JA, Merisca R, et al. Effectiveness of interventions to improve patient compliance: a meta analysis. Med Care. 2000;36:1138-1161.
11. Falloon IRH, Boyd JL, McGill CW. Family management in the prevention of morbidity of schizophrenia: clinical outcome of a two-year longitudinal study. Arch Gen Psychiatry. 1985;42:887-896.
12. Seltzer A, Roncar I, Garfinkel P. Effect of patient education on medication compliance. Can J Psychiatry. 1980;25:638-645.
13. Boczkowski JA, Zeichner A, DeSanto N. Neuroleptic compliance among chronic schizophrenic outpatients: An intervention outcome report. J Consult Clin Psychol. 1985;53:666-671.
14. Brown CS, Wright RG, Christensen DB. Association between type of medication instruction and patients' knowledge, side effects, and compliance. Hosp Community Psychiatry. 1987;38:55-60.
15. Macpherson R, Jerrom B, Hughes A. A controlled study of education about drug treatment in schizophrenia. Br J Psychiatry. 1996;168:709-717.
16. Eckman TA, Liberman RP, Phipps CC. Teaching medication management skills to schizophrenic patients. J Clin Psychopharmacol. 1990;10:33-38.
17. Frank AF, Gunderson JG. The role of the therapeutic alliance in the treatment of schizophrenia: relationship to course and outcome. Arch Gen Psychiatry. 1990;47:228-236.
18. Hayward P, Chan N, Kemp R, et al. Medication self-management: A preliminary report on an intervention to improve medication compliance. J Ment Health. 1995;4:511-517.
19. Dixon L, Weiden P, Torres M. Assertive community treatment and medication compliance in the homeless mentally ill. Am J Psychiatry. 1997;154:1302-1304.
20. Hogarty GE, Anderson CM, Reiss DJ, et al. The Environmental-Personal Indicators in the Course of Schizophrenia (EPICS) Research. Family psychoeducation, social skills training, and maintenance chemotherapy in the aftercare treatment of schizophrenia. Arch Gen Psychiatry. 1991;48:340-347.
21. Hogarty GE, Anderson CM, Reiss DJ, et al. Environmental/Personal Indicators in the Course of Schizophrenia Research Group. Family psychoeducation, social skills training and maintenance chemotherapy in the aftercare treatment of schizophrenia. Arch Gen Psychiatry. 1986;43:633-642.
22. Kelly GR, Scott JE. Medication compliance and health education among outpatients with chronic mental disorders. Med Care. 1990;28:1181-1197.
23. Xiong W, Phillips MR, Hu X, et al. Family-based intervention for schizophrenic patients in China: a randomised controlled trial. Br J Psychiatry. 1994;165:239-247.
24. Razali MS, Yahya H. Compliance with treatment in schizophrenia: a drug intervention program in a developing country. Acta Psychiatr Scand. 1995;91:331-335.
25. Atkinson JM, Coia DA, Gilmour WH, et al. The impact of education groups for people with schizophrenia on social functioning and quality of life. Br J Psychiatry. 1996;168:199-204.
26. Hornung WP, Kieserg A, Feldmann R, et al. Psychoeducational training for schizophrenic patients: background, procedure and empirical findings. Patient Educ Couns. 1996;29:257-268.
27. Kemp R, Hayward P, Appelwhaite G. Compliance therapy in psychotic patients: a randomised controlled trial. BMJ. 1996;312:345-349.
28. Buchkremer G, Klingerg S, Holle R, et al. Psychoeducational psychotherapy for schizophrenic patients and their key relatives of care givers: results of a 2-year follow-up. Acta Psychiatr Scand. 1997;96:483-491.
29. Homung WP, Klingberg S, Feldmann R, et al. Collaboration with drug treatment by schizophrenic patients with and without psychoeducational training: results of a 1-year follow-up. Acta Psychiatr Scand. 1998;97:213-219.
30. Kemp R, Kirov G, Everitt B, et al. Randomised controlled trial of compliance therapy. 18-month follow-up. Br J Psychiatry. 1998;172:413-419.
31. Merinder LB, Viuff AG, Laugesen HD, et al. Patient and relative education in community psychiatry: a randomized controlled trial regarding its effectiveness. Soc Psychiatry Psychiatr Epidemiol. 1999;34:287-294.
32. O'Donnell M, Parker G, Proberts M, et al. A study of client-focused case management and consumer advocacy: the community and consumer services project. Aust N Z J Psychiatry. 1999;33:684-693.
33. Vitolins MZ, Rand CS, Rapp SR, et al. Measuring adherence to behavioral and medical interventions. Control Clin Trials. 2000;21:188S-194S.
34. Perkins DO. Adherence to antipsychotic medications. J Clin Psychiatry. 1999;60:25-30.